Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil, ILAT, and tDCS in Chronic Post-stroke Aphasia
NCT04134416Phase 3Completed
- Sponsor
- Universidad de Málaga
- Start
- Jan 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in aphasia, sponsored by Universidad de Málaga. Started Jan 2019; status: completed.
02
Drugs
donepezil
03
Conditions
aphasia
Beyond the preview
Go deeper on NCT04134416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134416.